Tech Marvel: Paradigm Redefines Spinal Surgery

  • Proprio's Paradigm: A revolutionary real-time surgery guidance device
  • Precision Imaging: Dynamic 3D representation of the patient's anatomy during surgery
  • Data-Driven Future: Potential to enhance surgical training, improve patient outcomes, and resolve disputes.

The landscape of surgical procedures is witnessing a revolutionary transformation with the advent of cutting-edge technology. Proprio, an innovative startup, is leading this charge with its groundbreaking product, Paradigm. This real-time surgery guidance device is set to revolutionize spinal surgery and pave the way for advancements in various other complex surgical procedures. The medical community is abuzz with excitement as this technology promises to enhance surgical precision, improve patient outcomes, and potentially save lives.

Spinal deformations, such as scoliosis, have long been a challenging medical issue. These conditions can cause the natural curvature of the spine to become distorted, leading to severe disabilities if left untreated. The most effective treatment for these conditions involves complex spinal corrective surgeries that require the utmost precision.

Traditionally, surgeons have relied on static, pre-operative imagery combined with physical markers during surgery. However, this approach has its limitations. The imagery may become outdated if there are any delays in the surgery or if the patient’s anatomy changes. Such discrepancies can lead to complications, potentially jeopardizing the patient’s well-being.

Enter Paradigm – a game-changing technology developed by Proprio. This sophisticated device leverages real-time 3D imaging, computer vision, and hyper-precise sensors to provide dynamic, up-to-date information during surgery. The “Prism” imaging array equipped with multiple RGB cameras, infrared stereo cameras, and a dedicated depth sensor continuously tracks sub-millimeter movements and changes in the patient’s anatomy. The result is a precise and comprehensive representation of the surgical site, eliminating the need for physical markers and significantly reducing the risk of misalignment.

A simulated surgical procedure showcasing the capabilities of Paradigm left seasoned surgeons and medical professionals in awe. The device’s ability to continuously observe and register the positions of vertebrae in real time ensures unprecedented accuracy. Dr. Samuel Browd, a pediatric neurosurgeon and Proprio’s Chief Medical Officer, expressed genuine excitement and relief at the potential of this revolutionary technology.

In April, Paradigm received 510(k) clearance from the FDA, underscoring its safety and efficacy for “stereotaxic navigation for spine surgery.” With regulatory approval in hand, Proprio is now set to roll out the device in operating rooms across partnering hospitals. The first in-human cases are expected to take place during the summer.

While spinal surgery navigation is the primary focus of Paradigm, its applications extend far beyond. Joint reconstruction and other intricate surgical procedures stand to benefit from this technology’s unmatched precision and real-time imaging capabilities.

The immense potential of Paradigm also lies in the vast amount of data it collects during surgeries. The device records detailed 3D data, which can be invaluable for surgical training and procedure refinement. By analyzing data from hundreds of previous surgeries and combining it with real-time tracking during procedures, medical professionals can gain insights that lead to improved surgical techniques and enhanced patient outcomes.

The possibilities don’t stop there. The data-driven capabilities of Paradigm open doors for post-surgery analysis, insurance claims, and malpractice inquiries. Detailed 3D recordings allow for comprehensive reviews of surgical procedures, aiding in case reviews and resolving potential disputes.

As Proprio secures a substantial $43 million in new funding from investors, including DCVC, BOLD Capital Partners, Bird B. AG, Cota Capital, Intel, and HTC, the future of surgical procedures looks brighter than ever. The medical community eagerly anticipates Paradigm’s commercialization, heralding a new era of data-driven healthcare solutions that prioritize patient safety and surgical precision. The potential of this technology to save lives and enhance surgical procedures for both patients and surgeons is nothing short of awe-inspiring.

Visited 1 times, 1 visit(s) today

Stay ahead in the financial world – Sign Up to Rateweb’s essential newsletter for free. Get the latest insights on business trends, tech innovations, and market movements, directly to your inbox. Join our community of savvy readers and never miss an update that could impact your financial decisions.

Do you have a news tip for Rateweb reporters? Please email us at


Start trading with a free $30 bonus

Trade stocks, forex, commodities, metals and CFDs on stock indices with an internationally licensed and regulated broker. For all clients who open their first real account, XM offers a $30 trading bonus without any initial deposit needed. Learn more about how you can trade over 1000 instruments on the XM MT4 and MT5 platforms from your PC and Mac, or from a variety of mobile devices.


Personal Financial Tools

Below is a list of tools built to assist South Africans to make the best financial decisions:



South Africa’s primary source of financial tools and information

Contact Us


Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.